Corbus Pharmaceuticals Holding share price logo

Corbus Pharmaceuticals Holding Share Price

NASDAQ: CRBP

Small Cap

$9.84

-0.38

(-3.72%)

Live

as on

Corbus Pharmaceuticals Holding Stock Performance

as on April 25, 2026 at 2:10 am IST

  • Day's Low

    Day's High

    $9.81
    $10.20
    downward going graph

    0.30%

    Downside

    3.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.10
    $20.56
    downward going graph

    38.01%

    Downside

    108.94%

    Upside

    downward going graph

Corbus Pharmaceuticals Holding share price movements today

Previous Close
$10.22
Open
$10.17
Volume
104.0K
Day's Low - High
$9.81 - $10.20
52 Week Low - High
$6.10 - $20.56

Corbus Pharmaceuticals Holding Historical Returns

1 Month Return
+ 24.94 %
3 Month Return
+ 17.07 %
1 Year Return
+ 22.4 %
3 Year Return
+ 0.49 %
5 Year Return
-80.31 %

Corbus Pharmaceuticals Holding Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals Holding market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$185.9M

EPS (TTM)

-4.605

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-85.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-54.18%

Corbus Pharmaceuticals Holding vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals Holding with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Corbus Pharmaceuticals Holding image
Corbus Pharmaceuticals Holding
BUY$185.9M-80.31%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.4B129.51%133.38.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.3B99.68%28.5732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.3BNA121.875.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B56.77%17.9931.41%

Stock Returns calculator for Corbus Pharmaceuticals Holding Stock including INR - Dollar returns

The Corbus Pharmaceuticals Holding stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corbus Pharmaceuticals Holding investment value today

Current value as on today

₹1,30,140

Returns

₹30,140

(+30.14%)

Returns from Corbus Pharmaceuticals Holding Stock

₹17,844 (+17.84%)

Dollar Impact

₹12,295 (+12.3%)

Analyst Recommendation on Corbus Pharmaceuticals Holding Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals Holding. Average target price of $41.25

Corbus Pharmaceuticals Holding Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals Holding.

What analysts predicted

76.15%UPSIDE

Target Price

$41.25

Current Price

$9.84

Analyzed by

8 Analysts

Target

$41.25

Corbus Pharmaceuticals Holding target price $41.25, a slight upside of 76.15% compared to current price of $9.84. According to 8 analysts rating.

Corbus Pharmaceuticals Holding Stock’s Investor Sentiment and Interest

Search interest for Corbus Pharmaceuticals Holding Stock has increased by 85% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:85% versus previous 30 day period

Corbus Pharmaceuticals Holding Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
1
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
-15
0
-
0
Operating Income
-9
-10
-9
-10
-15
-12
-19
-19
-24
-21
EBITDA
-8
-7
-5
-9
-13
-9
-18
-17
-23
59
Interest Expense
0
0
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-8
-6
-9
-13
-9
-16
-17
-23
-20
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-10
-8
-6
-9
-13
-9
-16
-17
-23
-20
Net Profit Margin
0.00%
-594.27%
0.00%
0.00%
0.00%
-1354.89%
0.00%
0.00%
0.00%
0.00%

Corbus Pharmaceuticals Holding Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
2
4
36
3
0
-
-
-
-
Gross Profit
-13
-23
-43
-53
3
0
-1
-31
0
0
Operating Income
-19
-32
-56
-77
-122
-55
-34
-45
-48
-85
EBITDA
-19
-32
-56
-76
-121
-54
-38
-40
-37
-85
Interest Expense
-
0
-
0
1
1
2
2
1
-
Depreciation
-
0
0
1
1
1
1
1
0
0
Income Before Tax
-19
-32
-55
-71
-111
-45
-42
-44
-40
-78
Income Tax Expense
0
0
1
-2
0
0
13
-
-
-
Net Income
-19
-32
-55
-71
-111
-45
-55
-44
-40
-78
Net Profit Margin
-1046.27%
-1328.65%
-1154.48%
-197.69%
-2826.08%
-5166.42%
0.00%
0.00%
0.00%
0.00%

Corbus Pharmaceuticals Holding Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-6
-9
-13
-9
-16
-17
-23
-20
Operating Cash Flow
-6
-7
-8
-13
-10
-16
-16
-15
-15
Investing Cash Flow
10
-98
-16
-15
8
18
17
19
-57
Financing Cash Flow
-1
106
34
25
0
-
-
2
74
Change in Cash
2
0
9
-4
-2
1
1
6
1

Corbus Pharmaceuticals Holding Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-32
-55
-71
-111
-45
-42
-44
-40
-78
Operating Cash Flow
-27
-30
-45
-99
-48
-37
-36
-41
-64
Investing Cash Flow
0
-2
-2
0
-73
30
35
-121
-1
Financing Cash Flow
76
11
38
154
60
0
-2
166
77
Change in Cash
47
-20
-9
54
-60
-8
-3
3
11

Global Institutional Holdings in Corbus Pharmaceuticals Holding

Funds
Holdings
Stonepine Capital Management Llc
2.2%
Atle Fund Management AB
1%
Susquehanna International Group, LLP
1.28%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
1.03%
Geode Capital Management, LLC
0.96%
See all

Insights on Corbus Pharmaceuticals Holding

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CRBP stock has moved up by 24.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 6.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 52.7%

About Corbus Pharmaceuticals Holding

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
OrganisationCorbus Pharmaceuticals Holding
Headquarters500 River Ridge Drive, Norwood, MA, United States, 02062
IndustryBiotechnology
CEODr. Yuval Cohen Ph.D.
E-voting on sharesClick here to vote

Key Management of Corbus Pharmaceuticals Holding

Name

Title

Ms. Christina Bertsch M.A.

Vice President of Human Resources

Dr. Yuval Cohen Ph.D.

CEO & Director

Mr. Sean F. Moran CPA, M.B.A.

Chief Financial Officer

Dr. Dominic Smethurst M.A., M.D.

Chief Medical Officer

Dr. Ian Hodgson B.Sc., Ph.D.

Chief Operating Officer

Mr. G. Scott Goeken J.D., M.S.

General Counsel & Corporate Secretary

FAQs

What is Corbus Pharmaceuticals Holding share price today?

Corbus Pharmaceuticals Holding share price today is $9.84 as on . Corbus Pharmaceuticals Holding share today touched a day high of $10.2 and a low of $9.81.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals Holding share?

Corbus Pharmaceuticals Holding share touched a 52 week high of $20.56 on and a 52 week low of $6.1 on . Corbus Pharmaceuticals Holding stock price today i.e. is trending at $9.84,which is 52.14% down from its 52 week high and 61.31% up from its 52 week low.

What is Corbus Pharmaceuticals Holding's market capitalisation today?

Corbus Pharmaceuticals Holding market capitalisation is $0.00T as on .

How to invest in Corbus Pharmaceuticals Holding Stock (CRBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Corbus Pharmaceuticals Holding on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corbus Pharmaceuticals Holding Shares that will get you 0.1524 shares as per Corbus Pharmaceuticals Holding share price of $9.84 per share as on April 24, 2026 at 8:40 pm IST.

What is the minimum amount required to buy Corbus Pharmaceuticals Holding Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals Holding (CRBP) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Corbus Pharmaceuticals Holding stock (as per the Rupee-Dollar exchange rate as on ). Based on Corbus Pharmaceuticals Holding share’s latest price of $9.84 as on April 24, 2026 at 8:40 pm IST, you will get 1.0163 shares of Corbus Pharmaceuticals Holding. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals Holding has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals Holding stock has given -80.31% share price returns and 25.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?